Spyre Therapeutics Announces Grants of Inducement Awards
Spyre Therapeutics granted inducement equity awards to six new non-executive employees, consisting of 58,843 stock options and 2,134 restricted stock units. The stock options carry a 10-year term and an exercise price of $88.89 per share, which was the closing price on the grant date of July 1, 2026.
Key figures
- Rsus granted
- 2134
- Exercise price
- 88.89
- Options granted
- 58843
AI analysis
The rest of the AI analysis, red flags and sentiment are part of Signal8 Pro.
AI-generated analysis of a public disclosure. Not investment advice; verify against the original document.